Netherlands, June 1 -- Netherlands based GlaxoSmithKline B.V. has secured contract from Gemeente Rotterdam for General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents Shingrix . The value of the contract is worth 105000000 EUR .
Published by HT Digital Content Services with permission from Pivotal Sources....